Navigation Links
VIVUS to Present at the Credit Suisse 2011 Healthcare Conference
Date:11/3/2011

MOUNTAIN VIEW, Calif., Nov. 3, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at the Credit Suisse 2011 Healthcare Conference.

The VIVUS presentation will take place at the Arizona Biltmore Hotel in Phoenix, AZ on Thursday, November 10, 2011 at 9:30 a.m. MST.  A live webcast and 30-day archive of the presentation will be available at http://ir.vivus.com.About VIVUS VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead investigational product in clinical development, Qnexa®, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators. VIVUS received a Complete Response Letter, or CRL, to the initial Qnexa NDA on October 28, 2010. Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS has submitted an NDA for avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction, with an FDA action date of April 29, 2012. For more information about the company, please visit www.vivus.com.

 CONTACT: 

  

 

 VIVUS, Inc. Investor Relations:The Trout Group 

 

 Timothy E. Morris 

Brian KorbChief Financial Officer 

bkorb@troutgroup.com 

 

 650-934-52 

646-378-2923   
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. VIVUS Resubmits Qnexa NDA to the FDA
2. VIVUS Provides Regulatory Update on QNEXA
3. VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction
4. VIVUS Announces $45.8 Million Registered Direct Offering of Common Stock
5. VIVUS Reports Second Quarter and First Six Months 2011 Financial Results
6. VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results
7. VIVUS to Present at Three Upcoming Investor Conferences in March
8. VIVUS Provides Regulatory Update on QNEXA NDA
9. VIVUS to Present at the 2011 JP Morgan Healthcare Conference
10. VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA®
11. VIVUS to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... 2017  Prime Therapeutics LLC (Prime) released this statement from ... today,s Institute for Clinical and Economic Review,s (ICER) public ... and value of abuse-deterrent formulations (ADF) of opioids. Prime was ... the meeting. "The ... to the use of abuse-deterrent formulations (ADF) in opioids in ...
(Date:7/15/2017)... 15, 2017 Enterin Inc., a Philadelphia ... disease (PD), today announced the completion of a $12.7 million ... Ventures III, as well as the participation of existing investors. ... to have the support of New Ventures III and our ... validation of the potential of our platform technology to transform ...
(Date:7/13/2017)... Medical Products, a leader in medical product innovation and global patient ... for hospice patient care. ... Centurion Medical Products ... pain management and emotional comfort are part of a hospice,s primary ... preventing unneeded emergency department admission due to severe fecal impaction. One ...
Breaking Medicine Technology:
(Date:7/25/2017)... (PRWEB) , ... July 25, 2017 , ... SignatureCare Emergency ... in the Austin, TX area 24 Hours a day. , The Emergency ... TX. , “We’ve been open four months now and things are running smoothly,” ...
(Date:7/24/2017)... Angeles, CA (PRWEB) , ... July 24, 2017 , ... ... will spotlight doctors and the cosmetic surgeries they perform on a daily basis. ... performing the cosmetic surgery procedures they specialize in at their practices. , When ...
(Date:7/24/2017)... ... 24, 2017 , ... The International Essential Tremor Foundation (IETF) will host a ... (ET). The seminar will take place on Saturday, Aug. 26 at the Embassy Suites ... will run from 9 a.m. to 12 p.m., with check-in beginning at 8 a.m. ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... A CDC study shows that, although people ... of Caucasians (ages 18 to 29), had at least one case of sunburn within the ... time, which causes people to ignore the issue. However, only recently have people become conscientious ...
(Date:7/24/2017)... Atlanta, Georgia (PRWEB) , ... July 24, 2017 ... ... first comprehensive sleep management solution focused on delivering end-to-end sleep health ... (OSA) program. , Recent literature shows that adherence rates for positive airway pressure ...
Breaking Medicine News(10 mins):